Celldex Therapeutics (CLDX) PT Lowered to $36 at Goldman Sachs
Tweet
Share
E-mailGet Alerts CLDX Hot Sheet
Price: $40.38 +1.10%
Rating Summary:
18 Buy, 3 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 8 | Down: 6 | New: 26
Rating Summary:
18 Buy, 3 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 8 | Down: 6 | New: 26
Join SI Premium – FREE
Goldman Sachs analyst Richard Law lowered the price target on Celldex Therapeutics (NASDAQ: CLDX) to $36.00 (from $42.00) while maintaining a Neutral rating.
You May Also Be Interested In
- Stella International Holdings (1836:HK) (SLNLF) PT Lowered to HK$10 at Macquarie
- Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
- MidCap Financial Investment Corp (MFIC) PT Lowered to $9.50 at BofA Securities
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
